Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Third-Party Device Pilot Final Guidance Has Fewer Strings Attached

This article was originally published in The Gray Sheet

Executive Summary

Accredited third-party reviewers will be allowed to evaluate 510(k)s in a medical specialty area for which they have not processed applications before under the Center for Devices and Radiological Health's Feb. 2 final guidance on third-party review.

You may also be interested in...



CDRH Premarket Division Reviews Mulled By ODE Incoming Director Schultz

Incoming Office of Device Evaluation Director Daniel Schultz, MD, is considering quality reviews of CDRH's premarket programs in 2003

Third-Party Review Program Must Double Submissions For FDA To Break Even

CDRH predicts a two-fold increase in the third party program's current usage rate will be needed for the system to recoup costs.

Third-Party Review Program Must Double Submissions For FDA To Break Even

CDRH predicts a two-fold increase in the third party program's current usage rate will be needed for the system to recoup costs.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel